P. V. Chaturvedula

Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery.

J. Macor, R. Schartman, G. Thalody, 2013, Bioorganic & medicinal chemistry letters.

Design and synthesis of potent antagonists containing rigid spirocyclic privileged structures for the CGRP receptor.

J. Macor, G. Dubowchik, S. Pin, 2012, Bioorganic & medicinal chemistry letters.

Catalytic asymmetric syntheses of tyrosine surrogates.

J. Macor, G. Dubowchik, Qi Gao, 2008, The Journal of organic chemistry.

Discovery of (R)-4-(8-fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): a potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and effici

Kimberly A. Widmann, J. Macor, R. Schartman, 2008, Journal of medicinal chemistry.

Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines.

B. Beno, J. Macor, G. Dubowchik, 2016, Bioorganic & medicinal chemistry letters.

Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists.

Kimberly A. Widmann, Ping Chen, J. Macor, 2020, Bioorganic & medicinal chemistry letters.

Enantioselective synthesis of constrained phenylalanine analogues

J. Macor, G. Dubowchik, S. Mercer, 2010 .

The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 1.

Kimberly A. Widmann, J. Macor, R. Schartman, 2012, Bioorganic & medicinal chemistry letters.